wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26864988-02F71F15-CEB3-4E38-BF1A-FE593E578770
Q26864988-02F71F15-CEB3-4E38-BF1A-FE593E578770
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26864988-02F71F15-CEB3-4E38-BF1A-FE593E578770
Met in urological cancers
P2860
Q26864988-02F71F15-CEB3-4E38-BF1A-FE593E578770
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26864988-02F71F15-CEB3-4E38-BF1A-FE593E578770
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9a423b7632c931c1bce68f94f38e739264d6ef61
P2860
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.